Dose Escalation Study of Immunomodulatory Nanoparticles
Clinical trial NCT04751786 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04751786
- Sponsor
- Radboud University Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2025-07-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.